KalVista Pharmaceuticals (4XC1.F) Q1 2024 Earnings

Mar 11Confirmed
Q2 2023
Q2 2023
Q3 2023
Q1 2024
-0.77
-0.74
-0.71
-0.68

Details

Expected EPS
-0.68352331494
Actual EPS
-0.7684487999999999
Surprise EPS
-0.08
Surprise Percent
-12.42%

Description

⁨KalVista Pharmaceuticals⁩ (⁦4XC1.F⁩) has reported earnings of ⁦-0.7684487999999999⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts